Severe early-onset fetal growth restriction: What do we tell the prospective parents?
Journal
Prenatal diagnosis
ISSN: 1097-0223
Titre abrégé: Prenat Diagn
Pays: England
ID NLM: 8106540
Informations de publication
Date de publication:
Oct 2021
Oct 2021
Historique:
revised:
04
08
2021
received:
25
11
2020
accepted:
08
08
2021
pubmed:
15
8
2021
medline:
29
12
2021
entrez:
14
8
2021
Statut:
ppublish
Résumé
Fetal growth restriction (FGR) is a common complication of pregnancy, associated with higher risk of perinatal mortality and adverse health and developmental outcomes for surviving infants. True FGR relates to a pathological restriction of fetal growth resulting from complex interactions between maternal, placental, fetal, and environmental factors. Early-onset FGR (onset <32 weeks' gestation) is often first suspected at routine mid-trimester sonographic assessment of fetal morphology, or identified as part of the placental syndrome, commonly maternal pre-eclampsia. Prenatal investigations may identify the cause of FGR. Timing of delivery is guided by serial sonographic surveillance of fetal growth and well-being and maternal condition, balancing the risk of stillbirth with the benefits of advancing gestation. This is particularly pertinent to severe early-onset FGR, a leading iatrogenic cause of very preterm birth. Prognosis is largely determined by the severity of FGR and its causes, gestation at birth, and birthweight. Pregnancy termination may be considered. Antenatal care and delivery in a tertiary center, provided by a multi-disciplinary team with expertise in managing high-risk pregnancies, are imperative to optimizing outcomes.
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
1363-1371Informations de copyright
© 2021 John Wiley & Sons Ltd.
Références
Lees CC, Stampalija T, Baschat AA, et al. ISUOG Practice Guidelines: diagnosis and management of small-for-gestational-age fetus and fetal growth restriction. Ultrasound Obstet Gynecol. 2020;56(2):298-312.
Lees C, Marlow N, Arabin B, et al. Perinatal morbidity and mortality in early-onset fetal growth restriction: cohort outcomes of the trial of randomized umbilical and fetal flow in Europe (TRUFFLE). Ultrasound Obstet Gynecol. 2013;42(4):400-408.
Barker DJ. The fetal and infant origins of adult disease. Br Med J. 1990;301(6761):1111.
Unterscheider J, Daly S, Geary MP, et al. Optimizing the definition of intrauterine growth restriction: the multicenter prospective PORTO Study. Am J Obstet Gynecol. 2013;208(4):290 e1-6.
Gordijn SJ, Beune IM, Tilaganathan B, et al. Consensus definition of fetal growth restriction: a Delphi procedure. Ultrasound Obstet Gynecol. 2016;48(3):333-339.
Molina LCG, Odibo L, Zientara S, et al. Validation of Delphi procedure consensus criteria for defining fetal growth restriction. Ultrasound Obstet Gynecol. 2020;56(1):61-66.
Barker ED, McAuliffe FM, Alderdice F, et al. The role of growth trajectories in classifying fetal growth restriction. Obstet Gynecol. 2013;122(2 Pt 1):248-254.
Hadlock FP, Harrist RB, Sharman RS, Deter RL, Park SK. Estimation of fetal weight with the use of head, body, and femur measurements -- a prospective study. Am J Obstet Gynecol. 1985;151(3):333-337.
Ravishankar S, Redline RW. What obstetricians need to know about placental pathology. Obstet Gynecol Clin North Am. 2020;47(1):29-48.
Zur RL, Kingdom JC, Parks WT, Hobson SR. The placental basis of fetal growth restriction. Obstet Gynecol Clin North Am. 2020;47(1):81-98.
Feeley L, Mooney EE. Villitis of unknown aetiology: correlation of recurrence with clinical outcome. J Obstet Gynaecol. 2010;30(5):476-479.
Redline RW. Villitis of unknown etiology: noninfectious chronic villitis in the placenta. Hum Pathol. 2007;38(10):1439-1446.
Unterscheider J, Daly S, Geary MP, et al. Predictable progressive Doppler deterioration in IUGR: does it really exist? Am J Obstet Gynecol. 2013;209(6):539.e1-7.
Groom KM, David AL. The role of aspirin, heparin, and other interventions in the prevention and treatment of fetal growth restriction. Am J Obstet Gynecol. 2018;218(2S):S829-S840.
Abdel-Fattah SA, Bhat A, Illanes S, Bartha JL, Carrington D. TORCH test for fetal medicine indications: only CMV is necessary in the United Kingdom. Prenat Diagn. 2005;25(11):1028-1031.
Khalil A, Sotiriadis A, Chaoui R, et al. ISUOG Practice Guidelines: role of ultrasound in congenital infection. Ultrasound Obstet Gynecol. 2020;56(1):128-151.
Society for Maternal-Fetal Medicine. Society for Maternal-Fetal Medicine Consult Series #52: diagnosis and management of fetal growth restriction. Am J Obstet Gynecol. 2020;223(4):B2-B17.
Sagi-Dain L, Peleg A, Sagi S. Risk for chromosomal aberrations in apparently isolated intrauterine growth restriction: a systematic review. Prenat Diagn. 2017;37(11):1061-1066.
Zhu H, Lin S, Huang L, et al. Application of chromosomal microarray analysis in prenatal diagnosis of fetal growth restriction. Prenat Diagn. 2016;36(7):686-692.
Meler E, Sisterna S, Borrell A. Genetic syndromes associated with isolated fetal growth restriction. Prenat Diagn. 2020;40(4):432-446.
Helenius K, Sjörs G, Shah PS, et al. Survival in very preterm infants: an international comparison of 10 national neonatal networks. Pediatrics. 2017;140(6).
Pascal A, Govaert P, Oostra A, Naulaers G, Ortibus E, Van den Broeck C. Neurodevelopmental outcome in very preterm and very-low-birthweight infants born over the past decade: a meta-analytic review. Dev Med Child Neurol. 2018;60(4):342-355.
Extreme Prematury. https://www.bettersafercare.vic.gov.au/clinical-guidance/neonatal/extreme-prematurity
Lees CC, Marlow N, van Wassenaer-Leemhuis A, et al. 2 year neurodevelopmental and intermediate perinatal outcomes in infants with very preterm fetal growth restriction (TRUFFLE): a randomised trial. Lancet. 2015;385(9983):2162-2172.
Stampalija T, Arabin B, Wolf H, et al. Is middle cerebral artery Doppler related to neonatal and 2-year infant outcome in early fetal growth restriction? Am J Obstet Gynecol. 2017;216(5):521e1-521e13.
Sharp A, Cornforth C, Jackson R, et al. Maternal sildenafil for severe fetal growth restriction (STRIDER): a multicentre, randomised, placebo-controlled, double-blind trial. Lancet Child Adolesc Health. 2018;2(2):93-102.
Groom KM, McCowan LM, Mackay LK, et al. STRIDER NZAus: a multicentre randomised controlled trial of sildenafil therapy in early-onset fetal growth restriction. BJOG. 2019;126(8):997-1006.
EVERREST Consortium. Does vascular endothelial growth factor gene therapy safely improve outcome in severe early-onset fetal growth restriction? (EVERREST). Hum Gene Ther Clin Dev. 2015;26(2):82-84.
Doyle LW, Crowther CA, Middleton P, et al. Magnesium sulphate for women at risk of preterm birth for neuroprotection of the fetus. Cochrane Database Syst Rev. 2009(1):CD004661.
Sotiriadis A, Tsiami A, Papatheodorou S, Baschat AA, Sarafidis K, Makrydimas G. Neurodevelopmental outcome after a single course of antenatal steroids in children born preterm: a systematic review and meta-analysis. Obstet Gynecol. 2015;125(6):1385-1396.
Roberts D, Brown J, Medley N, et al. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev. 2017;3:CD004454.
Baschat AA, Cosmi E, Bilardo CM, et al. Predictors of neonatal outcome in early-onset placental dysfunction. Obstet Gynecol. 2007;109(2 Pt 1):253-261.
Kesavan K, Devaskar SU. Intrauterine growth restriction: postnatal monitoring and outcomes. Pediatr Clin North Am. 2019;66(2):403-423.
Sharma D, Farahbakhsh N, Shastri S, Sharma P. Intrauterine growth restriction - Part 2. J Matern Fetal Neonatal Med. 2016;29(24):4037-4048.
Sharma D, Shastri S, Sharma P. Intrauterine growth restriction: antenatal and postnatal aspects. Clin Med Insights Pediatr. 2016;10:67-83.
Rabe H, Gyte GM, Díaz-Rossello JL, Duley L. Effect of timing of umbilical cord clamping and other strategies to influence placental transfusion at preterm birth on maternal and infant outcomes. Cochrane Database Syst Rev. 2019;9:CD003248.
Gagliardi L, Rusconi F, Da Frè M, et al. Pregnancy disorders leading to very preterm birth influence neonatal outcomes: results of the population-based ACTION cohort study. Pediatr Res. 2013;73(6):794-801.
Sasi A, Abraham V, Davies-Tuck M, et al. Impact of intrauterine growth restriction on preterm lung disease. Acta Paediatr. 2015;104(12):e552-e556.
Steurer MA, Jelliffe-Pawlowski LL, Baer RJ, et al. Persistent pulmonary hypertension of the newborn in late preterm and term infants in California. Pediatrics. 2017;139(1).
Ahamed MF, Dar P, Vega M, Kim M, Gao Q, Havranek T. Early feeding tolerance in small for gestational age infants with normal versus abnormal antenatal Doppler characteristics. J Neonatal Perinatal Med. 2017;10(1):43-48.
Kempley S, Gupta N, Linsell L, et al. Feeding infants below 29 weeks' gestation with abnormal antenatal Doppler: analysis from a randomised trial. Arch Dis Child Fetal Neonatal Ed. 2014;99(1):F6-F11.
Abbott J, Berrington J, Bowler U, et al. The Speed of Increasing milk Feeds: a randomised controlled trial. BMC Pediatr. 2017;17(1):39.
Jacobs SE, Tobin JM, Opie GF, et al. Probiotic effects on late-onset sepsis in very preterm infants: a randomized controlled trial. Pediatrics. 2013;132(6):1055-1062.
Miller SL, Huppi PS, Mallard C. The consequences of fetal growth restriction on brain structure and neurodevelopmental outcome. J Physiol. 2016;594(4):807-823.
MacLennan AH, Thompson SC, Gecz J. Cerebral palsy: causes, pathways, and the role of genetic variants. Am J Obstet Gynecol. 2015;213(6):779-788.
Cheong JLY, Lee KJ, Boland RA, et al. Changes in long-term prognosis with increasing postnatal survival and the occurrence of postnatal morbidities in extremely preterm infants offered intensive care: a prospective observational study. Lancet Child Adolesc Health. 2018;2(12):872-879.
Voskamp BJ, Kazemier BM, Ravelli AC, et al. Recurrence of small-for-gestational-age pregnancy: analysis of first and subsequent singleton pregnancies in The Netherlands. Am J Obstet Gynecol. 2013;208(5):374.e1-6.
Loussert L, Vidal F, Parant O, Hamdi SM, Vayssiere C, Guerby P. Aspirin for prevention of preeclampsia and fetal growth restriction. Prenat Diagn. 2020;40(5):519-527.
Chen A, Roberts DJ. Placental pathologic lesions with a significant recurrence risk - what not to miss! APMIS. 2018;126(7):589-601.